Search results for:
dextroamphetamine
dextroamphetamine
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Dexedrine Spansule |
CAPSULE, EXTENDED RELEASE, ORAL |
5 mg |
|
|
|
|
| Dexedrine Spansule |
CAPSULE, EXTENDED RELEASE, ORAL |
10 mg, 15 mg |
|
|
|
|
| ProCentra, LiquADD |
SOLUTION, ORAL |
5 mg/5 mL |
|
|
|
|
| Dexedrine, Zenzedi |
TABLET, ORAL |
5 mg |
|
|
|
|
Last updated: Dec. 9, 2022
Immediate release formulations are automatically interchanged to the same daily dose of the extended-release formulation administered daily or BID (2nd dose prior to 4pm).
ORDERED FORMULATION
FORMULARY INTERCHANGE
dextroamphetamine
5 mg IR BID
10 mg IR once daily
dextroamphetamine(Dexedrine Spansule)
OR
OR
dextroamphetamine(Dexedrine Spansule)
dextroamphetamine(Dexedrine Spansule)
Dexedrine medication guide
LiquADD (dextroamphetamine solution) is formulary, not routinely stocked. The solution will be ordered as necessary.
Reviewed: May 27, 2008 (LiquADD), and 27 June 2017 (Dexedrine Spansule & Dexedrine, Zenzedi)
Updated: June 2017 (IR/ER formulations)